Skip to content

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

Clinical Evaluation of the CADence System in Detection of Coronary Artery Diseases

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01584622
Acronym
CADENCE
Enrollment
0
Registered
2012-04-25
Start date
2012-07-31
Completion date
2013-02-28
Last updated
2013-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.

Interventions

DEVICECADence System

Non-invasive detection of \> or equal to 50% stenosis in any of the major coronary arteries.

Sponsors

AUM Cardiovascular, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Willing and able to give informed consent * Indicated for angiography evaluation.

Exclusion criteria

* Pregnant or nursing * Presence of pacemaker/defibrillator * Presence of artificial valve * Presence of severe valve disease * Presence of congenital heart defect * Left Ventricular Assist Device (LVAD) * Presence of a bypass graft * Presence of scars on the site thorax areas * Coarctation of the aorta * Participation in trial within 30 days prior to collecting CADenceTM data * Asthma with wheezing * Inability to lie flat in the supine position * Acute STEMI * Heart Transplant * Recent Cocaine Use

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of CADence in detecting greater than or equal to 50% stenosis anywhere in the coronary tree.within three monthsThe CADence System will be considered to have demonstrated effectiveness in detecting greater than or equal to 50% coronary artery stenosis anywhere in the coronary tree if the estimated sensitivity as compared to angiography is statistically higher than 70%.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026